The US Food and Drug Administration (FDA) has approved Glaukos Corporation’s Epioxa, offering patients living with a rare ...

Glaukos’ Epioxa allows cross-linking therapy for keratoconus without requiring an incision. The biotech expects to launch the ...

Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, ...

Glaukos announced that the FDA has approved the new drug application for its topical drug therapy (Epioxa HD/Epioxa) for keratoconus. 1,2 This approval makes it the first FDA-approved corneal ...

To assess the efficacy and predictability of a minimal incision posterior approach levator plication technique for correction of involutional ptosis. Forty-four lids of 27 patients were included.

Samsara Vision Expands U.S. and Puerto Rico Clinical Study Sites for the Smaller-Incision New-Generation Implantable ...

Armed with a grant from NASA itself, robotic-assisted surgery will soon head for the final frontier. The U.S. space agency handed down the funding to send a miniaturized surgical robot to the ...

LINCOLN, Neb., & PLEASANTON, Calif.--(BUSINESS WIRE)--Virtual Incision Corporation, a medical device company pioneering first-of-its-kind miniaturized robots for laparoscopic surgery, today announced ...

LINCOLN, Neb.--(BUSINESS WIRE)--Virtual Incision Corporation, a medical device company pioneering the world’s first miniaturized robotic-assisted surgery (RAS) platform, today announced the U.S. Food ...

Please provide your email address to receive an email when new articles are posted on . In intraocular surgery, the placement of an incision has a lot of significance pertaining to the amount of ...